Senographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammography
Some Senographe Pristina systems either have a missing or an incorrect X-Ray Warning label, which is a nonconformance to FDA Regulation 21 CFR ¿1020.30(j).
U.S. and OUS.
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0875-2026